US Pharma and Biotech Summit 2024: Artificial intelligence and machine learning through the eyes of the FDA

In an interview with Pharm Exec Associate Editor Don Tracy, Tala Fakhouri, FDA Associate Director of Policy Analysis, discusses the use of artificial intelligence and machine learning in drug development.